Vermont’s statewide ACO-like system closely watched by state policymakers

The “zero year” of the OneCare Vermont system, operated much like an accountable care organization (ACO) on a statewide level, saw the program come within 1 percent of its financial target. With the model now expanded to cover about 18 percent of the state’s residents, other states are watching closely to see if it could be implemented elsewhere in the U.S.

Other states have Medicaid programs structured like OneCare Vermont, but Vermont’s model covers all patients, including the commercially insured. With the budget approved by the state’s Green Mountain Care Board earlier this year, $600 million will be dedicated to patient care throughout the state with providers to be paid a fixed amount on a monthly basis.

Nine of the state’s 14 hospitals are participating, along with one in neighboring New Hampshire, along with providers under Blue Cross Blue Shield plans and the University of Vermont Medical Center employee plans.

Integrating traditional aspects of care on the social determinants of health has helped patients like 57-year-old Toni Potvin, who has struggled with alcoholism and now has a social worker helping her navigate doctor’s orders, appointments and treatment—and keeping her out of the emergency room.

Read more from the Associated Press:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.